Cited by 463Meta-analysis and systematic reviewsArtificial Intelligence in Healthcare and EducationClinical practice guidelines implementation

Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension

Open access
Rivera, Samantha Cruz, Liu, Xiaoxuan, Chan, An-Wen, Denniston, Alastair K, Calvert, Melanie J·2020·BMJ

Abstract

The SPIRIT 2013 (The Standard Protocol Items: Recommendations for Interventional Trials) statement aims to improve the completeness of clinical trial protocol reporting, by providing evidence-based recommendations for the minimum set of items to be addressed. This guidance has been instrumental in promoting transparent evaluation of new interventions. More recently, there is a growing recognition that interventions involving artificial intelligence need to undergo rigorous, prospective evaluation to demonstrate their impact on health outcomes. The SPIRIT-AI extension is a new reporting guideline for clinical trials protocols evaluating interventions with an AI component. It was developed in parallel with its companion statement for trial reports: CONSORT-AI. Both guidelines were developed using a staged consensus process, involving a literature review and expert consultation to generate 26 candidate items, which were consulted on by an international multi-stakeholder group in a 2-stage Delphi survey (103 stakeholders), agreed on in a consensus meeting (31 stakeholders) and refined through a checklist pilot (34 participants). The SPIRIT-AI extension includes 15 new items, which were considered sufficiently important for clinical trial protocols of AI interventions. These new items should be routinely reported in addition to the core SPIRIT 2013 items. SPIRIT-AI recommends that investigators provide clear descriptions of the AI intervention, including instructions and skills required for use, the setting in which the AI intervention will be integrated, considerations around the handling of input and output data, the human-AI interaction and analysis of error cases. SPIRIT-AI will help promote transparency and completeness for clinical trial protocols for AI interventions. Its use will assist editors and peer-reviewers, as well as the general readership, to understand, interpret and critically appraise the design and risk of bias for a planned clinical trial.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.m3210

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Such regional bias could inadvertently exacerbate existing health disparities if models were not robustly validated in varied clinical contexts.

    “Such regional bias could inadvertently exacerbate existing health disparities if models were not robustly validated in varied clinical contexts36–38.”

    From A quantitative analysis of global AI medical studies: gaps in randomized controlled trials (2026) · cites this paper as [36]

    In Results, SPIRIT-AI 9 (page unavailable), the paper says AI algorithms may not generalise beyond their development environment. SPIRIT-AI 6a (ii) calls for validation evidence relevant to the intended setting and population, and the Discussion warns of harmful consequences from systematic errors. The paper does not specifically say that regional bias could exacerbate existing health disparities. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Reporting, evaluation, and appraisal frameworks including SPIRIT-AI, CONSORT-AI, DECIDE-AI, TRIPOD+AI, and PROBAST+AI have substantially strengthened the conceptual and reporting architecture for trustworthy clinical AI.

    “Reporting, evaluation, and appraisal frameworks including SPIRIT-AI, CONSORT-AI, DECIDE-AI, TRIPOD+AI, and PROBAST+AI have substantially strengthened the conceptual and reporting architecture for trustworthy clinical AI [10,11,12,13,14].”

    From Beyond Model Development in Healthcare AI: Post-Development Robustness, Post-Deployment Monitoring, and Lifecycle Governance—A Scoping Review of Reviews (2026) · cites this paper as [10]

    The Abstract identifies SPIRIT-AI as a reporting guideline for AI trial protocols, and the Discussion says it is expected, alongside CONSORT-AI, to improve trial quality. The source does not establish that these frameworks have already substantially strengthened clinical AI reporting, and it does not address the other frameworks named in the sentence. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • The SPIRIT 2025 update identified relevant SPIRIT or CONSORT extensions and related guidelines.

    “identified relevant SPIRIT or CONSORT extensions and related guidelines (eg,21 22 23 24)”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rivera, S. C., Liu, X., Chan, A.-W., Denniston, A. K., & Calvert, M. J.
Affiliations
  • University of Birmingham (GB)
  • University Hospitals Birmingham NHS Foundation Trust (GB)
  • University of Toronto (CA)
Corresponding author
Denniston, Alastair K
Venue
BMJ
Publisher
BMJ
Published
2020-09-09
Volume
370
Pages
m3210
ISSN
1756-1833 (ISSN-L)
OpenAlex
W3137245688
Cited by
463
References
51
Citations by year
2026: 179 · 2025: 84 · 2024: 61 · 2023: 49 · 2022: 42 · 2021: 41 · 2020: 6 · 2018: 1
FWCI
21.04
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by)
  • HighWire Press Open Archive (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
Funders
  • Microsoft Research
  • Brown University
  • Vanderbilt University
  • University of Pennsylvania
  • Harvard University
  • University of Washington
  • Harvard T.H. Chan School of Public Health
  • McGill University
  • Ottawa Hospital Research Institute
  • London School of Hygiene and Tropical Medicine
  • Université de Sherbrooke
  • Wellcome Trust
  • Green Templeton College, University of Oxford
  • National Institute for Health and Care Excellence
  • King's College Hospital NHS Foundation Trust
  • Alan Turing Institute (TU/ASG/R-SPEH-113)
  • University Hospitals Birmingham NHS Foundation Trust
  • UK Research and Innovation
  • DeepMind
  • Amsterdam University Medical Centers
  • Cancer Research UK (27294, 16895)
  • National Institute for Health and Care Research (CS-2014-14-023, NIHR201334)
  • University of Exeter
  • Imperial College London
  • King's College London
  • University College London
  • University of Oxford
  • University of Leeds
  • University of Birmingham
  • Institut National de la Santé et de la Recherche Médicale
  • Universiteit Leiden
  • Universiteit van Amsterdam
  • Women's College Hospital
  • University of Toronto
  • Indian Institute of Technology Madras
  • Hospital for Sick Children
  • Moorfields Eye Hospital NHS Foundation Trust
  • Berlin Institute of Health
  • Nature
  • Université de Paris
  • Sickkids Research Institute
  • Goddard Space Flight Center
  • School of Medicine, Vanderbilt University
  • City, University of London
  • Medical Research Council
  • Engineering and Physical Sciences Research Council
  • Research England
  • National Heart, Lung, and Blood Institute (K01HL141771)
  • National Eye Institute (K23EY029246)
  • Health Data Research UK
Topics
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Keywords
artificial intelligence interventions, reporting guidelines, human-AI interaction, risk of bias, CONSORT-AI, Delphi consensus
MeSH terms
Artificial Intelligence, Clinical Protocols, Clinical Trials as Topic, Humans, Research Design, Consensus, Checklist

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review